Approaches to Recombinant Histamine H3/H4 Receptor Expression in Mammalian Cells

  • Tadeusz Karcz
  • Urszula Cichoń
  • Katarzyna Kieć-KononowiczEmail author
Part of the Methods in Pharmacology and Toxicology book series (MIPT)


Recombinant receptor techniques are very commonly utilized in pharmacological studies nowadays. This state of affairs is a result of recent development of genetic engineering and DNA cloning methods, which made the expression of foreign genes in various cellular environments possible. The starting point for the application of recombinant proteins in studies on seven-transmembrane receptors (7TMRs) was marked by cloning of the first two 7TMRs-cholinergic and adrenergic receptors in the late 1980s. Resolving of gene sequences for successive receptors enabled the use of expression techniques for already well-characterized 7TMRs, but also for orphan receptors. Within the toolbox of available systems for expression of recombinant receptors, mammalian cells constitute the most frequently used model, since they offer a high probability for maintenance of full functional activity of artificially overexpressed receptors. Taking into consideration the importance of mammalian expression systems in relation to current challenges of molecular pharmacology, some of the available protocols for recombinant 7TMRs production in mammalian cells will be discussed in this chapter.

In the first part, details of transient transfection of CHO cells with genetic construct encoding for fusion protein of histamine H3 receptor and fluorescent protein-mCherry using polyethylenimine as transfection reagent will be given. Then, methods for establishing a monoclonal cell lines stably expressing receptor protein following the lipofection procedure will be presented. Finally, the utility of retroviral expression systems for recombinant receptor production will be discussed using the histamine H4 receptor as an example.

Key words

Histamine H3 and H4 receptors Mammalian expression systems Polyethylenimine (PEI) transfection Recombinant receptors Retroviral transduction Stable transfection 



The authors acknowledge the financial support of Polish National Science Centre within the frame of Meastro grant No. 2011/02/A/NZ4/00031 and Preludium grant No. 2011/01/N/NZ4/01126, which enabled the development and optimization of protocols described in this manuscript.


  1. 1.
    Hill SJ (2006) G-protein-coupled receptors: past, present and future. Br J Pharmacol 147(Suppl 1):S27–S37PubMedPubMedCentralGoogle Scholar
  2. 2.
    Bockaert J, Brand C, Journot L (1997) Do recombinant receptor assays provide affinity and potency estimates? Ann N Y Acad Sci 812:55–70CrossRefPubMedGoogle Scholar
  3. 3.
    Kenakin T (1996) The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol Rev 48:413–463PubMedGoogle Scholar
  4. 4.
    Sautel M, Milligan G (2000) Molecular manipulation of G-protein-coupled receptors: a new avenue into drug discovery. Curr Med Chem 7:889–896CrossRefPubMedGoogle Scholar
  5. 5.
    Sarramegna V, Talmont F, Demange P et al (2003) Heterologous expression of G-protein-coupled receptors: comparison of expression systems from the standpoint of large-scale production and purification. Cell Mol Life Sci 60:1529–1546CrossRefPubMedGoogle Scholar
  6. 6.
    Tate CG, Grisshammer R (1996) Heterologous expression of G-protein-coupled receptors. Trends Biotechnol 14:426–430CrossRefPubMedGoogle Scholar
  7. 7.
    Colosimo A, Goncz KK, Holmes AR et al (2000) Transfer and expression of foreign genes in mammalian cells. Biotechniques 29:314–318 320-312, 324PubMedGoogle Scholar
  8. 8.
    Mortensen RM, Kingston RE (2009) Selection of transfected mammalian cells. Curr Protoc Mol Biol 86:9.5.1–9.5.13Google Scholar
  9. 9.
    Makrides SC (1999) Components of vectors for gene transfer and expression in mammalian cells. Protein Expr Purif 17:183–202CrossRefPubMedGoogle Scholar
  10. 10.
    Jordan M, Schallhorn A, Wurm FM (1996) Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res 24:596–601CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Meissner P, Pick H, Kulangara A et al (2001) Transient gene expression: recombinant protein production with suspension-adapted HEK293-EBNA cells. Biotechnol Bioeng 75:197–203CrossRefPubMedGoogle Scholar
  12. 12.
    Reed SE, Staley EM, Mayginnes JP et al (2006) Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adeno-associated virus vectors. J Virol Methods 138:85–98CrossRefPubMedGoogle Scholar
  13. 13.
    Ehrhardt C, Schmolke M, Matzke A et al (2006) Polyethylenimine, a cost-effective transfection reagent. Signal Transduct 6:179–184CrossRefGoogle Scholar
  14. 14.
    Benjaminsen RV, Mattebjerg MA, Henriksen JR et al (2013) The possible “proton sponge” effect of polyethylenimine (PEI) does not include change in lysosomal pH. Mol Ther 21:149–157CrossRefPubMedGoogle Scholar
  15. 15.
    Hawley-Nelson P, Ciccarone V, Moore ML (2008) Transfection of cultured eukaryotic cells using cationic lipid reagents. Curr Protoc Mol Biol 81:9.4.1–9.4.17Google Scholar
  16. 16.
    Hermans E (2004) Generation of model cell lines expressing recombinant G-protein-coupled receptors. Methods Mol Biol 259:137–153PubMedGoogle Scholar
  17. 17.
    Freshney RI (2005) Culture of animal cells: a manual of basic technique, 5th edn. Wiley-Liss, Hoboken, NJCrossRefGoogle Scholar
  18. 18.
    Baldi L, Hacker DL, Adam M et al (2007) Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectives. Biotechnol Lett 29:677–684CrossRefPubMedGoogle Scholar
  19. 19.
    Zaremba ML, Borowski J (2004) Mikrobiologia lekarska: podręcznik dla studentów medycyny, 3rd edn. Wydawnictwo Lekarskie PZWL, WarszawaGoogle Scholar
  20. 20.
    Cepko C, Pear W (2001) Overview of the retrovirus transduction system. Curr Protoc Mol Biol 36:9.9.1–9.9.16Google Scholar
  21. 21.
    Miller AD, Buttimore C (1986) Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6:2895–2902CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Jayapal KP, Wlaschin KF, Hu W-S et al (2007) Recombinant protein therapeutics from CHO cells—20 years and counting. Chem Eng Prog 103:40Google Scholar
  23. 23.
    Graham FL, Smiley J, Russell WC et al (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59–74CrossRefPubMedGoogle Scholar
  24. 24.
    Atwood BK, Lopez J, Wager-Miller J et al (2011) Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis. BMC Genomics 12:14CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Thomas P, Smart TG (2005) HEK293 cell line: a vehicle for the expression of recombinant proteins. J Pharmacol Toxicol Methods 51:187–200CrossRefPubMedGoogle Scholar
  26. 26.
    Witte DG, Yao BB, Miller TR et al (2006) Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand. Br J Pharmacol 148:657–670CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Markowitz D, Goff S, Bank A (1988) Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167:400–406CrossRefPubMedGoogle Scholar
  28. 28.
    Hughes P, Marshall D, Reid Y et al (2007) The costs of using unauthenticated, over-passaged cell lines: how much more data do we need? Biotechniques 43:575 577-578, 581-572CrossRefPubMedGoogle Scholar
  29. 29.
    Jacobsen L, Hughes P (2007) Effects of passage number on cell line transfection. Biochemica 3:2Google Scholar
  30. 30.
    Emi N, Friedmann T, Yee JK (1991) Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J Virol 65:1202–1207PubMedPubMedCentralGoogle Scholar
  31. 31.
    Burns JC, Friedmann T, Driever W et al (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci U S A 90:8033–8037CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2017

Authors and Affiliations

  • Tadeusz Karcz
    • 1
  • Urszula Cichoń
    • 1
  • Katarzyna Kieć-Kononowicz
    • 1
    Email author
  1. 1.Department of Technology and Biotechnology of Drugs, Faculty of PharmacyJagiellonian University Medical CollegeKrakówPoland

Personalised recommendations